Form 4: Standard BioTools CFO's Routine Stock Withholding

Standard BioTools' Chief Financial Officer, Hanjoon Alex Kim, reported a routine disposition of 12,739 common shares to cover tax obligations from vested restricted stock units.

Summary

• Standard BioTools Inc. Chief Financial Officer, Hanjoon Alex Kim, reported a transaction on November 20, 2025.
• The transaction involved the disposition of 12,739 shares of common stock.
• These shares were withheld from the reporting person to satisfy tax withholding obligations.
• The tax obligations arose upon the vesting of restricted stock units (RSUs) granted on May 20, 2024, and March 21, 2025.
• The deemed price for the disposition was $1.28 per share.
• Following this transaction, Mr. Kim beneficially owns 2,415,086 shares of common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes related to vested equity compensation, which is a neutral event in terms of company performance or outlook.

Positives

• The underlying vesting of restricted stock units indicates continued compensation and retention of a key executive.

Negatives

• A disposition of shares, even for tax purposes, reduces the insider's direct equity stake, though this is a common and expected event with RSU vesting.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to equity compensation, common across all industries for publicly traded companies. It does not reflect specific industry trends or competitive dynamics.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine compliance filing for an insider's equity compensation tax obligations.
• Positive for the executive as it represents the realization of previously granted equity compensation.

Key Dates

Keywords

Standard BioTools, LAB, Hanjoon Alex Kim, Chief Financial Officer, CFO, Insider Transaction, Form 4, Restricted Stock Units, RSU, Tax Withholding, Equity Compensation